AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.

Lutnick made the remarks in a CNBC interview, shortly after U.S. President Donald Trump said during a Cabinet meeting that ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...